Skip to content

Ductal Carcinoma in Situ of the Breast

Spend $50 to get a free DVD!

ISBN-10: 0683182447

ISBN-13: 9780683182446

Edition: 1st

Authors: Melvin J. Silverstein

List price: $149.00
Blue ribbon 30 day, 100% satisfaction guarantee!
what's this?
Rush Rewards U
Members Receive:
Carrot Coin icon
XP icon
You have reached 400 XP and carrot coins. That is the daily max!

Description:

Now in its Second Edition, this pioneering classic text contains the most complete discussion of DCIS available in the medical market. Includes a DCIS review and also covers biology, detection, diagnosis, pathology, psychology, and the treatment of the disease. Contributing surgeons, pathologists, radiation and medical oncologists, psychiatrists, and a medical geneticist write chapters in this multidisciplinary and comprehensive book. In cases where applicable, both sides of an issue are presented and followed by a summary or commentary from the editors. New to this edition are the deletion of four previous chapters and the addition of seven new chapters. There is a greater emphasis on screening and early detection that includes the increased role of genetics and molecular biology, as well as therapeutic options. The book also reviews standard treatment practices of many breast centers around the world.
Customers also bought

Book details

List price: $149.00
Edition: 1st
Publisher: Lippincott Williams & Wilkins
Binding: Cloth Text 
Pages: 665
Size: 8.50" wide x 11.00" long
Language: English

History and Epidemiologyp. 1
History of Ductal Carcinoma in Situp. 3
Why Study Ductal Carcinoma in Situp. 12
The Natural History of Ductal Carcinoma in Situ of the Breastp. 17
The Epidemiology of Breast Carcinoma in Situp. 22
Carcinogenesis and Biologyp. 35
Biologic Characteristics of Ductal Carcinoma in Situp. 37
Prognostic Factors in Ductal Carcinoma in Situp. 49
HER-2/neu Gene Amplification and Overexpression in Ductal Carcinoma in Situp. 54
New Insights into the Pathogenesis of in Situ Carcinomas of the Breast by Means of Comparative Genomic Hybridization (CGH)p. 67
Model Systems for Ductal Carcinoma in Situp. 77
Detection and Evaluationp. 85
Mammographic Appearances of in Situ Carcinomasp. 87
Ductal Carcinoma in Situ: A Radiological Perspectivep. 105
Roles of Breast Magnetic Resonance Imaging for Ductal Carcinoma in Situp. 118
Ultrasound of Ductal Carcinoma in Situp. 128
Biopsy Techniquesp. 171
Minimally Invasive Biopsyp. 173
Breast Biopsy and Oncoplastic Surgery for the Patient with Ductal Carcinoma in Situ: Surgical, Pathologic, and Radiologic Issuesp. 185
Pathologyp. 205
Practical Pathology of Duct Carcinoma in Situ: How to Derive Optimal Data from the Pathologic Examinationp. 207
The Van Nuys Ductal Carcinoma in Situ Classification: An Updatep. 222
Angiogenesis in Ductal Carcinoma in Situ of the Breastp. 234
The Local Distribution of Ductal Carcinoma in Situ of the Breast: Whole-Organ Studiesp. 240
Large-Section (Macrosection) Histologic Slidesp. 249
Predicting Local Recurrence in Patients with Ductal Carcinoma in Situp. 255
The Diagnostic Reproducibility of Ductal Carcinoma in Situp. 264
Treatment of Ductal Carcinoma in Situp. 273
Surgical Overview of the Treatment of Ductal Carcinoma in Situp. 275
Overview of Conservative Surgery and Radiation Therapy Ductal Carcinoma in Situp. 287
The Lagios Experiencep. 303
Treatment of Subclinical Ductal Carcinoma in Situ of the Breast by Local Excision and Surveillance: An Updated Personal Experiencep. 308
Ductal Carcinoma in Situ: Experience at Nottingham City Hospital 1973 through 2000p. 322
Ductal Carcinoma in Situ: The Memorial Sloan-Kettering Cancer Center Experiencep. 329
The Van Nuys/USC Experience by Treatmentp. 337
Ductal Carcinoma in Situ: The Edinburgh Experiencep. 343
The Florence Experiencep. 348
Bayreuth-Erlangen Experience of "Risk-Adapted" Therapy of Ductal Carcinoma in Situp. 354
An International Collaborative Study: A 15-Year Experiencep. 359
Breast-Conserving Surgery Plus Radiation Therapy in Ductal Carcinoma in Situ: The Institut Curie Experiencep. 367
Joint Center for Radiation Therapy Experiencep. 373
The Impact of Young Age on Outcome in Patients with Ductal Carcinoma in Situ: The William Beaumont Hospital Experiencep. 381
Breast Conserving Therapy for Ductal Carcinoma in Situ: The Van Nuys Experience with Excision Plus Radiation Therapyp. 394
Ductal Carcinoma in Situ: Collected Experience of the French Regional Comprehensive Cancer Centersp. 400
Should All Ductal Carcinoma in Situ Patients Receive Radiation Therapy and Is Partial Breast Irradiation an Option?p. 407
Randomized Trial Overviewp. 414
Prospective Clinical Trials: The National Surgical Adjuvant Breast Project Experiencep. 420
Prevention of Invasive Breast Cancer in Women with Ductal Carcinoma in Situ: An Update of the National Surgical Adjuvant Breast and Bowel Project Experiencep. 432
An Update on European Organization for Research and Treatment of Cancer Trial 10853 for Ductal Carcinoma in Situ of the Breastp. 447
Radiotherapy and Tamoxifen after Complete Excision of Ductal Carcinoma in Situ of the Breastp. 453
Tools for Selecting Patients for Breast Conservation with and without Radiation Therapyp. 457
The University of Southern California/Van Nuys Prognostic Indexp. 459
Problems with the Use of the Van Nuys Prognostic Indexp. 474
Margin Width as the Sole Predictor of Local Recurrence in Patients with Ductal Carcinoma in Situ of the Breastp. 482
Adjuvant Therapy, Prevention, and Hormone Replacement Therapyp. 495
Can the New Prevention Strategies Reduce the Incidence of Ductal Carcinoma in Situ?p. 497
Tamoxifen and/or Hormone Replacement Therapy after Treatment for Ductal Carcinoma in Situp. 502
Tamoxifen Chemoprevention for Ductal Carcinoma in Situ: Magic Bullet or Misstep?p. 508
Other Issuesp. 513
Mastectomy and Immediate Reconstruction for Extensive Ductal Carcinoma in Situ of the Breastp. 515
Ductal Carcinoma in Situ with Microinvasionp. 523
Management of the Contralateral Breastp. 530
Extensive Intraductal Component in Association with Invasive Breast Cancersp. 536
Salvage of Local-Regional Failurep. 539
Outcome after Invasive Local Recurrence in Patients with Ductal Carcinoma in Situ of the Breastp. 545
Axillary Dissection for Ductal Carcinoma in Situp. 554
The Role of Sentinel Lymph Node Biopsy in Ductal Carcinoma in Situ: The Memorial Sloan-Kettering Opinionp. 565
Explaining Ductal Carcinoma in Situ to Patients: The Role of Specific Information and Absolute Risksp. 571
Ductal Carcinoma in Situ of the Male Breastp. 577
Interstitial Therapy of Ductal Carcinoma in Situ: Where Does It Stand?p. 581
The Ductal Carcinoma in Situ Consensus Conferencesp. 585
The European Organization for Research and Treatment of Cancer Ductal Carcinoma in Situ Consensus Meetingsp. 587
The Classification and Treatment of Ductal Carcinoma in Situ of the Breast: Summary of the 1997 and 1999 Consensus Conferencesp. 594
Other Noninvasive Breast Cancers and Preneoplastic Diseasesp. 601
Breast-Conserving Treatment of Paget's Disease of the Breast with Radiotherapyp. 603
Paget's Diseasep. 607
Lobular Carcinoma in Situp. 615
Pathology of Ductal Carcinoma in Situ: Proliferative and Nonproliferative Benign Breast Diseasep. 635
Conclusionp. 641
Editors' Consensusp. 643
Indexp. 651
Table of Contents provided by Blackwell. All Rights Reserved.